DexTech Medical Competitors and Similar CompaniesClear all

DexTech Medical's competitors and similar companies include MEI Pharma, Ascendis Pharma, Astex Pharmaceuticals and Celltrion Healthcare.

	DexTech Medical DexTech Medical is a research company specializing in urological oncology.	MEI Pharma MEI Pharma is a San Diego-based oncology company focused on the clinical development of novel therapies for cancer.	Ascendis Pharma Ascendis Pharma is a biopharmaceutical company that specializes in endocrinology and oncology.	Astex Pharmaceuticals Astex Pharmaceuticals is a company dedicated to the discovery and development of small molecule therapeutics with a focus on oncology.	Celltrion Healthcare Celltrion Healthcare is a biopharmaceutical company specializing in oncology, influenza, psoriasis, and arthritis.,
Founding Date	Founding Date 2004	Founding Date 2000	Founding Date 2007	Founding Date 1991	Founding Date 2002
Type	Type Public	Type Public	Type Public	Type Subsidiary	Type Public
Tags	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma
Locations	Locations Uppsala, SE HQ	Locations San Diego, US HQ	Locations Hellerup, DK HQ Heidelberg, DE Palo Alto, US	Locations Pleasanton, US HQ Cambridge, GB	Locations Incheon, KR HQ
Employees	Employees 2	Employees 4025% increase	Employees 1,017	Employees 512% decrease	Employees 6301% increase
Valuation ($)	Valuation ($) 80.3 m	Valuation ($) 21.1 m	Valuation ($) 7.7 b	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $65.3m (FY, 2024)	Revenue (est.) €720.1m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) ₩2t (FY, 2022)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods €93.1m (FY, 2025)	Cost of goods N/A	Cost of goods ₩1.4t (FY, 2022)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit €627.1m (FY, 2025)	Gross profit N/A	Gross profit ₩664.7b (FY, 2022)
Net income	Net income (kr4.8m) (FY, 2025)	Net income $17.8m (FY, 2024)	Net income (€228m) (FY, 2025)	Net income N/A	Net income ₩147.2b (FY, 2022)
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 1.1m	Total funding raised $ 85.8m	Total funding raised N/A	Total funding raised N/A